← Back to Treatments

CARBAMAZEPINE

CARBAMAZEPINE

Manufacturer: Alembic Pharmaceuticals Inc.

Indicated for:
Atypical hemolytic uremic syndrome with complement gene abnormalityEpilepsy with generalized tonic-clonic seizures aloneMixed functioning pituitary adenomaTrigeminal neuralgiaGlossopharyngeal neuralgia
⚠️

Black Box Warning (Boxed Warning)

A Boxed Warning is the FDA's strongest safety warning — it indicates serious or life-threatening risks identified during clinical trials or post-market surveillance. It does not mean the medication is unsafe for all patients; your prescriber weighs these risks against the benefits for your specific situation. Source: FDA-approved prescribing information.

View full prescribing information on DailyMed (NLM) ↗

FDA-Approved Indications (5)

Carbamazepine is indicated for use as an anticonvulsant drug for partial seizures with complex symptomatology (psychomotor, temporal lobe)

Population: all ages

Carbamazepine is indicated for use as an anticonvulsant drug for generalized tonic-clonic seizures (grand mal)

Population: all ages

Carbamazepine is indicated for use as an anticonvulsant drug for mixed seizure patterns which include partial or generalized seizures

Population: all ages

Carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia

Population: all ages

Beneficial results have also been reported in glossopharyngeal neuralgia

Population: all ages

Indications & Usage

INDICATIONS AND USAGE Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: 1. Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. 2. Generalized tonic-clonic seizures (grand mal). 3. Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS , General). Trigeminal Neuralgia Carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. Beneficial results have also been reported in glossopharyngeal neuralgia. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.

💙 Support Programs

View all →
Carbamazepine, Carbamazepin
Novartis
Copay card ↗Apply ↗
Carbamazepine ER
Novartis
Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.